Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel anticancer agents imparted in recent Novartis patent

Feb. 15, 2007

Novel tubulin polymerization inhibitors identified at Threshold Pharmaceuticals

Feb. 15, 2007

Ariad grants commercial license to Argent technology to CellNexus

Feb. 14, 2007

Micromet exercises option for Morphotek antibody

Feb. 14, 2007

PEP-005 Topical studied in phase II trial for superficial BCC

Feb. 14, 2007

SIR-Spheres, bevacizumab + chemotherapy studied for metastatic colorectal cancer

Feb. 14, 2007

Nexavar extends survival in advanced hepatocellular carcinoma

Feb. 13, 2007

ViaCell will not advance CB-001 based on phase I findings

Feb. 13, 2007

Apotherapy CD40 research program receives E.U. funding

Feb. 13, 2007

Guidelines devised for photodynamic therapy for nonmelanoma skin cancer

Feb. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...